Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.765 USD | +8.36% | +2.92% | -42.50% |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
05-09 | Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight | MT |
Sales 2024 * | 28.8M 2.29B | Sales 2025 * | 24.83M 1.98B | Capitalization | 438M 34.83B |
---|---|---|---|---|---|
Net income 2024 * | -223M -17.75B | Net income 2025 * | -250M -19.9B | EV / Sales 2024 * | 7.14 x |
Net cash position 2024 * | 232M 18.46B | Net cash position 2025 * | 95.12M 7.57B | EV / Sales 2025 * | 13.8 x |
P/E ratio 2024 * |
-2.02
x | P/E ratio 2025 * |
-2.08
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Editas Medicine, Inc.
1 day | +8.36% | ||
1 week | +2.92% | ||
Current month | +11.80% | ||
1 month | -4.19% | ||
3 months | -21.28% | ||
6 months | -23.86% | ||
Current year | -42.50% |
Managers | Title | Age | Since |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 31/05/22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 16/05/23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 23/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 02/09/21 |
David Scadden
BRD | Director/Board Member | 71 | 05/02/19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 27/07/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.83% | 2 M€ | -25.75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 5.825 | +9.49% | 1 086 634 |
10/05/24 | 5.32 | -4.32% | 1,637,650 |
09/05/24 | 5.56 | +10.43% | 2,718,539 |
08/05/24 | 5.035 | -11.36% | 4,346,916 |
07/05/24 | 5.68 | +0.35% | 1,567,154 |
Delayed Quote Nasdaq, May 13, 2024 at 06:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.50% | 438M | |
+25.36% | 44.96B | |
+0.36% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.57% | 26.08B | |
-20.92% | 19.03B | |
+6.92% | 12.75B | |
+29.01% | 12.06B | |
-3.82% | 11.75B |
- Stock Market
- Equities
- EDIT Stock